Segall Bryant & Hamill LLC Acquires 132,779 Shares of Aveanna Healthcare Holdings Inc. $AVAH

Segall Bryant & Hamill LLC boosted its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 425.8% during the first quarter, Holdings Channel.com reports. The firm owned 163,966 shares of the company’s stock after acquiring an additional 132,779 shares during the period. Segall Bryant & Hamill LLC’s holdings in Aveanna Healthcare were worth $1,056,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Caitong International Asset Management Co. Ltd grew its stake in shares of Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares in the last quarter. Summit Securities Group LLC bought a new position in shares of Aveanna Healthcare in the 1st quarter valued at about $53,000. Quantbot Technologies LP purchased a new position in Aveanna Healthcare in the second quarter worth about $43,000. Entropy Technologies LP purchased a new position in Aveanna Healthcare in the third quarter worth about $107,000. Finally, Oxford Asset Management LLP bought a new stake in Aveanna Healthcare during the second quarter worth approximately $64,000. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Stock Down 0.3%

Shares of NASDAQ:AVAH opened at $9.33 on Thursday. The firm has a market capitalization of $2.03 billion, a PE ratio of 7.91, a price-to-earnings-growth ratio of 0.93 and a beta of 1.90. The business has a 50 day simple moving average of $8.53 and a two-hundred day simple moving average of $7.71. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.74 and a 1 year high of $10.32. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The firm had revenue of $647.91 million for the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare’s revenue was up 15.9% on a year-over-year basis. On average, equities analysts predict that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on AVAH shares. Barclays upped their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a research report on Wednesday, June 3rd. Truist Financial increased their price target on Aveanna Healthcare from $9.00 to $11.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. Finally, Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $10.78.

Insiders Place Their Bets

In other news, major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of the business’s stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $36,455,577.60. Following the completion of the sale, the insider directly owned 13,450,547 shares of the company’s stock, valued at approximately $83,931,413.28. The trade was a 30.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Patrick A. Cunningham sold 125,000 shares of the company’s stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total transaction of $948,750.00. Following the completion of the transaction, the insider owned 212,755 shares in the company, valued at approximately $1,614,810.45. The trade was a 37.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 31,305,664 shares of company stock worth $215,555,910. Insiders own 5.30% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.